Paper Details

  1. Home
  2. Paper Details

Safety issues and management of toxicities associated with new treatments for multiple myeloma.

Author: BrioliAnnamaria, HochhausAndreas, MüggeLars-Olof, Von Lilienfeld-ToalMarie

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

New drugs for multiple myeloma (MM) have significantly improved patient outcomes, but have also introduced a new range of adverse events. Four novel agents, carfilzomib, elotuzumab, daratumumab, and panobinostat, have been approved for MM treatment. This review provides guidance to physicians for recognizing and managing toxicities associated with these new therapies.
Paper Details　
Original Abstract of the Article :
In the last decade, the availability of new drugs for the treatment of Multiple Myeloma (MM) significantly improved patients' outcomes, but also raised attention towards a new spectrum of adverse events. Recently, four novel agents with different mechanisms of action (carfilzomib, elotuzumab, daratu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17474086.2017.1284584

データ提供：米国国立医学図書館（NLM）

Navigating the Side Effects of Multiple Myeloma Treatments

Multiple myeloma (MM) is a challenging blood cancer, and recent advancements in treatment have led to improved outcomes for patients. However, these new therapies often come with a new set of side effects. This review examines the safety issues and management of toxicities associated with new treatments for MM. The researchers aim to provide healthcare professionals with the knowledge needed to recognize and manage these potential complications. It's like creating a map to guide practitioners through the desert of potential side effects, ensuring the well-being of their patients.

The Challenge of Multiple Myeloma Treatment

This review highlights the importance of careful monitoring and prompt management of toxicities associated with new MM treatments. The researchers provide a comprehensive overview of the potential side effects and strategies for addressing them. It's like having a guidebook to the desert of side effects, ensuring that healthcare professionals are equipped to navigate potential challenges and provide optimal care for their patients.

Multiple Myeloma: A Long and Winding Road

MM is a complex disease with a variable course. This review provides valuable information for healthcare professionals, helping them manage the potential toxicities associated with new treatments. It underscores the importance of careful patient monitoring and appropriate intervention to minimize the negative impact of these side effects and improve overall outcomes. It's like providing a roadmap through the desert of MM treatment, guiding patients and their doctors towards a more manageable and hopeful journey.

Dr.Camel's Conclusion

This comprehensive review provides valuable information for healthcare professionals regarding the potential side effects of new treatments for multiple myeloma. It emphasizes the need for careful monitoring and prompt management of toxicities to ensure the well-being of patients navigating this challenging disease.

Date :
  1. Date Completed 2017-05-18
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

28116920

DOI: Digital Object Identifier

10.1080/17474086.2017.1284584

Related Literature

Article Analysis
・Side Effects of panobinostat
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.